Japan Intellectual Property Rights: IMMUNOMODULATING POLYNUCLEOTIDES AND THEIR ANTIBODY CONJUGATES AND USE METHODS THEREOF

Japan, July 20 -- TALLAC THERAPEUTICS INC has got intellectual property rights for 'IMMUNOMODULATING POLYNUCLEOTIDES AND THEIR ANTIBODY CONJUGATES AND USE METHODS THEREOF.' Other related details are as follows:

Application Number: JP,2024-124259

Category (FI): C12N5/0786,A61K48/00,C12N15/115@Z,C07K16/28,C07K14/555,A61P43/00,111,A61K39/395@C,A61K39/395@L,A61K39/395@E,A61K39/395@T,A61K39/395@D,A61K39/395@N,A61K45/00,A61P43/00,121,A61P7/00,A61P35/00,A61P35/02,A61P37/02,A61P37/06,A61P37/04,A61K47/68,A61K31/7088,C12N15/11@Z,C12N15/117@Z,C12N5/10,C12N5/0781,C12N5/0784,C07K14/705

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 31, 2024

Publication Date: Dec. 3, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.